FR2834996B1 - Methode d'identification de substances capables de moduler la differenciation adipocytaire - Google Patents

Methode d'identification de substances capables de moduler la differenciation adipocytaire

Info

Publication number
FR2834996B1
FR2834996B1 FR0200582A FR0200582A FR2834996B1 FR 2834996 B1 FR2834996 B1 FR 2834996B1 FR 0200582 A FR0200582 A FR 0200582A FR 0200582 A FR0200582 A FR 0200582A FR 2834996 B1 FR2834996 B1 FR 2834996B1
Authority
FR
France
Prior art keywords
adipocytary
differentiation
modulating
substances capable
identifying substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0200582A
Other languages
English (en)
Other versions
FR2834996A1 (fr
Inventor
Bart Staels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genfit SA
Original Assignee
Genfit SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0200582A priority Critical patent/FR2834996B1/fr
Application filed by Genfit SA filed Critical Genfit SA
Priority to PCT/FR2003/000157 priority patent/WO2003060106A1/fr
Priority to CA002472016A priority patent/CA2472016A1/fr
Priority to EP03712261A priority patent/EP1468078A1/fr
Priority to JP2003560193A priority patent/JP2005525099A/ja
Priority to AU2003216739A priority patent/AU2003216739A1/en
Priority to US10/501,525 priority patent/US7368286B2/en
Publication of FR2834996A1 publication Critical patent/FR2834996A1/fr
Application granted granted Critical
Publication of FR2834996B1 publication Critical patent/FR2834996B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0200582A 2002-01-18 2002-01-18 Methode d'identification de substances capables de moduler la differenciation adipocytaire Expired - Fee Related FR2834996B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0200582A FR2834996B1 (fr) 2002-01-18 2002-01-18 Methode d'identification de substances capables de moduler la differenciation adipocytaire
CA002472016A CA2472016A1 (fr) 2002-01-18 2003-01-17 Methode d'identification de substances capables de moduler la differenciation adipocytaire
EP03712261A EP1468078A1 (fr) 2002-01-18 2003-01-17 Methode d'identification de substances capables de moduler la differenciation adipocytaire
JP2003560193A JP2005525099A (ja) 2002-01-18 2003-01-17 脂肪細胞分化を調節することのできる物質を同定する方法
PCT/FR2003/000157 WO2003060106A1 (fr) 2002-01-18 2003-01-17 Methode d'identification de substances capables de moduler la differenciation adipocytaire
AU2003216739A AU2003216739A1 (en) 2002-01-18 2003-01-17 Method and device for identifying substances capable of modulating adipocyte differentiation
US10/501,525 US7368286B2 (en) 2002-01-18 2003-01-17 Method and device for identifying substances capable of modulating adipocyte differentiation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0200582A FR2834996B1 (fr) 2002-01-18 2002-01-18 Methode d'identification de substances capables de moduler la differenciation adipocytaire

Publications (2)

Publication Number Publication Date
FR2834996A1 FR2834996A1 (fr) 2003-07-25
FR2834996B1 true FR2834996B1 (fr) 2004-12-03

Family

ID=8871341

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0200582A Expired - Fee Related FR2834996B1 (fr) 2002-01-18 2002-01-18 Methode d'identification de substances capables de moduler la differenciation adipocytaire

Country Status (7)

Country Link
US (1) US7368286B2 (fr)
EP (1) EP1468078A1 (fr)
JP (1) JP2005525099A (fr)
AU (1) AU2003216739A1 (fr)
CA (1) CA2472016A1 (fr)
FR (1) FR2834996B1 (fr)
WO (1) WO2003060106A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2004053124A1 (ja) * 2002-12-06 2006-04-13 塩野義製薬株式会社 糖尿病治療剤又は予防剤のスクリーニング方法
FR2894595B1 (fr) * 2005-12-08 2012-08-31 Daniel Jouvance Rech S Et Creation Methode pour identifier un compose cosmetiquement actif capable d'agir sur les pre-adipocytes
AU2012314501B2 (en) 2011-09-27 2017-02-16 Genfit Derivatives of 6-substituted triazolopyridazines as Rev-Erb agonists
CN105008396A (zh) 2012-11-25 2015-10-28 加利福尼亚大学董事会 刺激皮下脂肪形成的肽
WO2015184125A1 (fr) 2014-05-28 2015-12-03 The Regents Of The University Of California Peptides, compositions et procédés pour stimuler l'adipogenèse sous-cutanée

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780512B1 (fr) * 1998-06-25 2003-10-17 Lipha Utilisation de recepteurs de la famille rev-erb pour le criblage de substances utiles dans le traitement des dysfonctionnements du metabolisme lipidique
GB0101933D0 (en) 2001-01-25 2001-03-07 Astrazeneca Ab Therapy

Also Published As

Publication number Publication date
US7368286B2 (en) 2008-05-06
WO2003060106A1 (fr) 2003-07-24
US20050032064A1 (en) 2005-02-10
EP1468078A1 (fr) 2004-10-20
FR2834996A1 (fr) 2003-07-25
AU2003216739A1 (en) 2003-07-30
JP2005525099A (ja) 2005-08-25
CA2472016A1 (fr) 2003-07-24

Similar Documents

Publication Publication Date Title
DE60207183D1 (de) Vorrichtung zur Beobachtung biologischer Daten
DE602004011164D1 (de) Vorrichtung und Methode zur Anzeige von Informationen
DE602004026860D1 (de) Objektidentifikationsmedium und identifikationsverfahren
DE60224321D1 (de) Endoskopsystem zur Verwendung von normalem Licht und Fluoreszenz
FR2853427B1 (fr) Procede d'identification aveugle de melanges de sources aux ordres superieurs
DE602004001887D1 (de) System zur Übertragung von Gesichtsinformation
DE602004015408D1 (de) Verfahren zur analyse von polymer-populationen
EP1700707A4 (fr) Support d'identification et procede d'identification d'un support d'identification
DE602004012900D1 (de) Verfahren zur Analyse von Leistungsinformation
DE60209131D1 (de) Automatisiertes system zur filtration von flüssigkeiten sowie zur erfassung und aufzeichnung von messdaten
DE60214946D1 (de) Verfahren und System zur Bereitstellung von Informationen
DE60308782D1 (de) Vorrichtung und Methode zur Hinderniserkennung
ATA12472001A (de) Verfahren und chip zur analyse von nukleinsäuren
DE60332707D1 (de) Medium-identifikation und identifizierungsverfahren für ein objekt
BR0301577B1 (pt) método e sistema de identificação de cartucho cirúrgico.
DE60309087D1 (de) System und Methode zur Reglung von optischen Verstärkern
FI20021451A0 (fi) Menetelmä bakteerien tunnistamiseksi
FR2854483B1 (fr) Procede d'identification de sons specifiques
DE50203510D1 (de) Verfahren zur erkennung und identifizierung von objekten
DE60323579D1 (de) Methode zur Separierung von Nukleinsäuren und dafür verwendbare Reagenz
AU2002329869A1 (en) Methods for the specific detection of redox-active tags and the use thereof for capillary gel electrophoresis and dna sequencing
ATE480637T1 (de) Methode zur bestimmung der biologischen aktivität von difibrotid
DE602004028192D1 (de) Vorrichtung zur Aufnahme biologischer Daten
FR2834996B1 (fr) Methode d'identification de substances capables de moduler la differenciation adipocytaire
DE60324253D1 (de) Spezifische multiplex-analyse von nukleinsäuren

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091030